TOPLINE: Statin use in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) patients showed significant survival benefits, with a 45% lower risk for overall mortality […]
TOPLINE: A systematic review identified a prevalence range of tinea pedis in children from 0.03% to 15.6%, with notable demographic and geographic variations. Dermatophytes, particularly Trichophyton […]
Share on PinterestThe FDA has not yet approved the use of topical finasteride to treat hair loss, a popular treatment sold by telehealth companies. Narongrit Doungmanee/Getty […]
TOPLINE: In patients with type 2 diabetes (T2D), sodium-glucose cotransporter 2 (SGLT2) inhibitors significantly increase the risk for falls, and combined use with glucagon-like peptide 1 […]
The presence of five key proteins in the blood was strongly associated with the development of metabolic dysfunction-associated steatotic liver disease (MASLD) as much as 16 […]
The US Food and Drug Administration (FDA) has approved penpulimab-kcqx (Akeso Biopharma) in combination with cisplatin or carboplatin and gemcitabine as first-line treatment for adults with […]
The Food and Drug Administration is advising consumers not to purchase or use Artrifan King, a product promoted and sold for joint pain on various websites, […]
MADRID — Recent research on the progression and treatment of psychosis is prompting some experts to ask: Are substance-induced psychosis (SIP) and primary psychosis fundamentally different? […]
The National Institute for Health and Care Excellence (NICE) has recommended ribociclib (Kisqali, Novartis) as an adjuvant treatment for early breast cancer in patients at high […]
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPTReject
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.